Trial study at St Thomas’s Pain Management Centre shows dramatic effectiveness to treat chronic intractable pain PRETORIA, South Africa, 27 March, 2018 — Xavant Technology (Pty) Ltd today announced the launch of their Stimpod NMS460 in the U.K. The Stimpod NMS460, a non-invasive neuromodulation device, is focused on the symptomatic relief and management of neuropathic pain as well as an adjunctive treatment in the management of post-surgical pain, post-traumatic acute pain problems, and an adjunct… Source: RealWire